Late-onset cardiotoxicity of chemotherapy and radiotherapy.

نویسندگان

  • B Dietz
  • K G van der Hem
چکیده

An increasing number of patients with malignant lymphoma are becoming long-term survivors following treatment with chemotherapy (CT) and/or radiotherapy (RT). Therefore, late therapy-related complications are becoming increasingly clear. We present three young patients to illustrate the dire consequences of late-onset cardiotoxicity as sequel to potentially curative treatment. We advise yearly life-long follow-up of CT/RT patients treated with curative intent. Echocardiography should be performed when cardiac murmurs arise. Prevention of further cardiac damage by reducing other cardiac risk factors as well as endocarditis prophylaxis when indicated is recommended.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

NT-proBNP as Early Marker of Subclinical Late Cardiotoxicity after Doxorubicin Therapy and Mediastinal Irradiation in Childhood Cancer Survivors

BACKGROUND Childhood cancer survivors treated with anthracyclines and mediastinal irradiation are at risk for late onset cardiotoxicity. AIMS OF THE STUDY To assess the role of N-terminal pro-brain natriuretic peptide (NT-proBNP) and tissue Doppler imaging (TDI) as early predictors of late onset cardiotoxicity in asymptomatic survivors of childhood cancer treated with doxorubicin with or with...

متن کامل

Roadmap for biomarkers of cancer therapy cardiotoxicity.

Contemporary cancer treatment uses multiple modalities such as chemotherapy, targeted therapy and radiotherapy. These therapies, often used in combination, are associated with an increased risk of cardiotoxicity, specifically cardiomyopathy and heart failure. Cardiologists and oncologists are faced with the challenge of maximising the clinical benefit from cancer therapy while minimising the ri...

متن کامل

Diagnosis of Chemotherapy-Induced Cardiotoxicity

Cardiotoxicity is a rising issue connected to use of chemotherapy and radiotherapy in the treatment of neoplastic diseases. Early diagnosis during follow-up is of paramount importance, and careful surveillance is recommended. Evaluation of left ventricular ejection fraction by echocardiography and nuclear medicine techniques is widely used in clinical practice; however, their sensitivity in det...

متن کامل

Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran

Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. Dexrazoxane is co-administrated with doxorubicin to prevent its cardiotoxicity. Here we have explored some alternative food or drugs to be used in absence of dexrazoxane since it’s not readily available in Iran at this time. Keywords: Pediatric, chemotherapy, doxorubicin, cardiotoxicity, dexrazoxane, Iran.

متن کامل

Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicity.

Side effects of chemo-radiotherapy reduce the quality and also the survivability of patients. The consequent fatigue and infections, related to myelodepression, act to reduce the dose-intensity of the protocol. Late side effects of chemo-radiotherapy include secondary tumours, acute myeloid leukemias and cardiotoxicity. Side effects of chemotherapy are related to oxidative stress produced by th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Netherlands journal of medicine

دوره 61 6  شماره 

صفحات  -

تاریخ انتشار 2003